| Cell line name |
Mel-XY1 |
|---|
| Synonyms |
MEL-XY1 |
|---|
| Accession |
CVCL_A0GT |
|---|
| Resource Identification Initiative |
To cite this cell line use: Mel-XY1 (RRID:CVCL_A0GT) |
|---|
| Comments |
Group: Patented cell line.
Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2830.
Population: Caucasian.
Derived from site: Metastatic; Lung; UBERON=UBERON_0002048. |
|---|
| HLA typing |
Source: PubMed=17448240
| Class I | | HLA-A | A*02:01,23 | | HLA-B | B*18,37 |
|
|---|
| Disease |
Melanoma (NCIt: C3224) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Male |
|---|
| Age at sampling |
Age unspecified |
|---|
| Category |
Cancer cell line |
|---|
| Publications | PubMed=17448240; DOI=10.1186/1479-5876-5-19; PMCID=PMC1863425
Erika Maria von Euw, Maria Marcela Barrio, David Furman, Michele Bianchini, Estrella M. Levy, Cassian Yee, Yong-Qing Li, Rosa Wainstok de Calmanovici, Jose Mordoh;
Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8(+) T lymphocytes.
J. Transl. Med. 5:19.1-19.13(2007) PubMed=21993558; DOI=10.1038/jid.2011.312
Mariana Aris, Mariana Rodriguez Zubieta, Marina Colombo, Juan Martin Arriaga, Michele Bianchini, Myriam Alperovich, Alicia Ines Bravo, Maria Marcela Barrio, Jose Mordoh;
MART-1- and gp100-expressing and -non-expressing melanoma cells are equally proliferative in tumors and clonogenic in vitro.
J. Invest. Dermatol. 132:365-374(2012) Patent=US8501168
Jose Mordoh, Maria Marcela Barrio, Erika Maria von Euw;
Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods.
Patent number US8501168, 06-Aug-2013 |
|---|
| Cross-references |
|---|
| Encyclopedic resources |
Wikidata; Q108820897
|
|---|
| Entry history |
|---|
| Entry creation | 23-Sep-2021 |
|---|
| Last entry update | 29-Jun-2023 |
|---|
| Version number | 4 |
|---|
